Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1745studies shown
Showing 1,261-1,272 of 1,745
Drug study icon
CompletedNCT00477672

Safety study of safety and Efficacy of Pimavanserin in Schizophrenia

This study is completed in the United States, in France, in the United Kingdom, .... It is testing safety and Efficacy of Pimavanserin for Schizophrenia.

In United Kingdom
SchizophreniaDrugOver 40 Years
Countries
United States, France, United Kingdom, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00550238

Safety study of pimavanserin in Schizophrenia

This study is completed in the United States, in France, in Canada, .... It is testing pimavanserin for Schizophrenia.

In United Kingdom
SchizophreniaDrugOver 40 Years
Countries
United States, France, Canada, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT05145413

KarXT for schizophrenia

This study is completed in the United States, in the United Kingdom, in Bulgaria, .... It is testing KarXT for schizophrenia.

In United Kingdom
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, United Kingdom, Bulgaria, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
CompletedNCT02935725

PharmacoMRI Effects of AUT00206 in Healthy Males

This study is completed in the United Kingdom. It is testing pharmacoMRI Effects of AUT00206 for Schizophrenia.

In United Kingdom
SchizophreniaDrugFrom 18 Years to 45 Years
Countries
United Kingdom
Sponsor
Autifony Therapeutics Limited
Condition
Schizophrenia
Drug study icon
CompletedNCT05741710

Use of Methylone for PTSD

This study is completed in the United States, in the United Kingdom, and in Ireland. It is testing use of Methylone for PTSD.

In United Kingdom
PTSDDrugFrom 18 Years to 65 Years
Countries
United States, United Kingdom, Ireland
Sponsor
Transcend Therapeutics
Condition
PTSD
Drug study icon
CompletedNCT01655680

ABT-126 for schizophrenia

This study is completed in the United States, in the United Kingdom, and in Russia. It is testing ABT-126 for schizophrenia.

In United Kingdom
SchizophreniaDrugFrom 20 Years to 65 Years
Countries
United States, United Kingdom, Russia
Sponsor
AbbVie (prior sponsor, Abbott)
Condition
Schizophrenia
Drug study icon
CompletedNCT04693351

Troriluzole for OCD

This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing troriluzole for OCD.

In United Kingdom
OCDDrugFrom 18 Years to 65 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Biohaven Pharmaceuticals, Inc.
Condition
OCD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.